BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 17041886)

  • 21. [Immunophenotyping of eighty six children with acute lymphoblastic leukemia by three-color flow cytometry].
    Wan S; Gong W; Sun X; Xu J; Tian D
    Zhonghua Xue Ye Xue Za Zhi; 2002 Feb; 23(2):83-6. PubMed ID: 12015077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.
    Auewarakul CU; Lauhakirti D; Promsuwicha O; Munkhetvit C
    Ann Hematol; 2006 Feb; 85(2):108-12. PubMed ID: 16320053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of DNA aneuploidy as a tumor marker].
    Takamoto S
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2329-37. PubMed ID: 2751314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
    Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
    Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine immunophenotyping in acute leukemia: Role in lineage assignment and reassignment.
    Qadir M; Barcos M; Stewart CC; Sait SN; Ford LA; Baer MR
    Cytometry B Clin Cytom; 2006 Sep; 70(5):329-34. PubMed ID: 16739218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic heterogeneity of B cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Kampalath B; Barcos MP; Stewart C
    Am J Clin Pathol; 2003 Jun; 119(6):824-32. PubMed ID: 12817430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells.
    Belov L; Huang P; Chrisp JS; Mulligan SP; Christopherson RI
    J Immunol Methods; 2005 Oct; 305(1):10-9. PubMed ID: 16125720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias.
    Suggs JL; Cruse JM; Lewis RE
    Exp Mol Pathol; 2007 Dec; 83(3):471-3. PubMed ID: 17963747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of gene expression profiling for diagnosing acute leukemias.
    Kern W; Kohlmann A; Schnittger S; Schoch C; Haferlach T
    Rev Clin Exp Hematol; 2005 Jun; 9(1):E1. PubMed ID: 16027103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multi-parametric analysis for leukemic immunophenotyping].
    Ujiie M; Sonoda A; Todoroki T; Amano H; Uchida T; Kawai Y; Watanabe K
    Rinsho Byori; 1998 Nov; 46(11):1163-7. PubMed ID: 9868303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative contributions of enzyme cytochemistry and flow cytometric immunophenotyping to the evaluation of acute myeloid leukemias with a monocytic component and of flow cytometric immunophenotyping to the evaluation of absolute monocytoses.
    Dunphy CH; Orton SO; Mantell J
    Am J Clin Pathol; 2004 Dec; 122(6):865-74. PubMed ID: 15539379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of CD117 in the evaluation of acute leukemias by flow cytometry.
    Newell JO; Cessna MH; Greenwood J; Hartung L; Bahler DW
    Cytometry B Clin Cytom; 2003 Mar; 52(1):40-3. PubMed ID: 12599181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usefulness of monoclonal antibodies for immunophenotyping in leukemia].
    Sagawa K
    Nihon Rinsho; 1992 Jun; 50(6):1209-16. PubMed ID: 1518136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of minimal residual disease in acute leukemias by flow cytometry].
    Scolnik MP
    Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
    Terstappen LW; Könemann S; Safford M; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
    Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I; Beason K; Yu C; Hughson M
    Cancer Genet Cytogenet; 2005 Nov; 163(1):62-7. PubMed ID: 16271957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New methodologic approaches for immunophenotyping acute leukemias.
    Basso G; Buldini B; De Zen L; Orfao A
    Haematologica; 2001 Jul; 86(7):675-92. PubMed ID: 11454522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic quantitative features of patients with acute myeloid leukemia.
    Pereira FG; Metze K; Costa FP; Lima CS; Lorand-Metze I
    Neoplasma; 2006; 53(2):155-60. PubMed ID: 16575472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CD20 on acute lymphoblastic leukemia cells in children.
    Pituch-Noworolska A; Hajto B; Mazur B; Sońta-Jakimczyk D; Balwierz W; Janota-Krawczyk E; Kowalska H; Malinowska I; Modzelewska M; Wasik M
    Neoplasma; 2001; 48(3):182-7. PubMed ID: 11583286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases.
    Karube K; Aoki R; Nomura Y; Yamamoto K; Shimizu K; Yoshida S; Komatani H; Sugita Y; Ohshima K
    Pathol Int; 2008 Feb; 58(2):89-97. PubMed ID: 18199158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.